
Opinion|Videos|September 4, 2024
PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging
Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD
Jaideep Sohi, MD, and Jeremie Calais, MD, examine the comparative merits of PSMA PET and Gallium-Based PET while exploring the application of NCCN Guidelines in prostate cancer imaging protocols.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the NCCN Guidelines' recommendations for gallium-based versus non-gallium-based PET agents in prostate cancer imaging, and how does PSMA PET imaging impact prostate cancer care in your view?
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
A Closer Look at the Evolution and Emerging Insights with Amyloid and Tau PET for Dementia and Alzheimer’s Disease
2
Study Suggests FDG-PET Better than CT for Assessing Treatment Response for Metastatic Breast Cancer
3
Rethinking Our Approach to Acquisitions of Coronary Computed Tomography Angiography (CCTA) Scans
4
Research Highlights from SCCT 2026
5










